MASHINIi

TScan Therapeutics, Inc..

TCRX.US | Research and experimental development on natural sciences and engineering

TScan Therapeutics, Inc. is a biopharmaceutical company focused on developing T-cell receptor (TCR)-engineered T cell therapies for the treatment of cancer. The company's lead product candidates are designed to recognize and eliminate cancer cells by targeting specific antigens associated with vario...Show More

Ethical Profile

Mixed.

TScan Therapeutics, a clinical-stage biotech, focuses on developing TCR-T cancer therapies for conditions like AML and solid tumors, currently in Phase I trials with collaborations including Novartis and Amgen. This mission holds high potential for future health impact. The company's operations necessitate robust cybersecurity and ethical AI governance, as it relies heavily on sensitive patient data, including genetic information, for its TargetScan platform. Ensuring data integrity and patient privacy is paramount. TScan also maintains an SEC-mandated confidential financial concern hotline.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-40
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess TScan Therapeutics, Inc. on Better Health for All.

Fair Money & Economic Opportunity

0

TScan Therapeutics, Inc. is a biopharmaceutical company focused on developing T-cell receptor therapies. The company's core business does not involve offering lending, deposit, or other financial services to consumers or businesses.

1
Therefore, all KPIs related to fair money and economic opportunity, which are designed for financial institutions, are not applicable to TScan Therapeutics, Inc.

Fair Pay & Worker Respect

0

No specific, concrete data points were found across the provided articles for any of the KPIs under the 'Fair Pay & Worker Respect' value. While articles mention general benefits like health insurance and PTO, executive compensation for a CFO (not CEO), and salary ranges for some roles, they do not provide the quantitative data required by the rubric for any KPI, such as percentages of workforce covered, specific ratios, or incident rates.

1
Therefore, no KPIs can be scored.

Fair Trade & Ethical Sourcing

0

No specific, quantitative evidence related to fair trade certification share, audit frequency, forced or child labor incidents, supply chain traceability, remediation speed, ethical clause coverage in supplier contracts, materials risk index, or supplier diversity spend was found in the provided articles.

1
The documents primarily focus on financial performance, business strategy, risk factors, internal ethical conduct, and employee-related aspects, without addressing the company's supply chain practices concerning fair trade and ethical sourcing.

Honest & Fair Business

-40

TScan Therapeutics, Inc. maintains a confidential and anonymous financial concern hotline, established as required by the SEC's final ruling on Audit Committees.

1
This hotline is for submitting complaints regarding accounting, internal accounting controls, or auditing matters.
2
However, the available evidence does not provide details on independent investigation processes, the policy's scope, training frequency, or the effectiveness of the program.
3

Kind to Animals

0

The provided articles focus on TScan Therapeutics' immunotherapy research and clinical trials for cancer treatment.

1
They explicitly state that no data related to animal welfare, animal testing, or any of the specified metrics for the 'Kind to Animals' value is present.
2
Therefore, no KPIs can be scored based on the available evidence.

No War, No Weapons

0

The provided articles explicitly state that no sustainability data or specific, concrete information relevant to the 'No War, No Weapons' ethical value, including any association with arms manufacturing, military contracts, or conflict facilitation, is available for TScan Therapeutics, Inc. (TCRX.US).

1
Therefore, no KPIs can be scored.

Planet-Friendly Business

0

No data relevant to Planet-Friendly Business KPIs for TCRX.US was found in the provided articles.

1
The articles either pertained to a different company or explicitly stated that no ESG or sustainability data was present for TScan Therapeutics.
2

Respect for Cultures & Communities

0

No specific, concrete data points were found in the provided articles for any of the KPIs related to 'Respect for Cultures & Communities'. The articles primarily discuss financial results, clinical trial progress, and employee-centric workplace culture, such as being named a 'Top Place to Work' in Massachusetts based on employee surveys.

1
There is no information regarding community engagement, cultural impact assessments, local employment ratios, grievance mechanisms for communities, or any other metrics relevant to this ethical value.
2

Safe & Smart Tech

0

No evidence available to assess TScan Therapeutics, Inc. on Safe & Smart Tech.

Zero Waste & Sustainable Products

0

No evidence available to assess TScan Therapeutics, Inc. on Zero Waste & Sustainable Products.

Own TScan Therapeutics, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.